sirolimus-PNP (Samyang)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug Namesirolimus-PNP (Samyang)
Drug Alias Namesirolimus polymer nanoparticleB6049B5833B6070
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular GlueSmall molecules > Polymers and chelators
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsImmunosuppressantsProtein synthesis inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSamyang Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSamyang Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A